Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

31.60 -2.32 (-6.84%)
Official Closing Price Updated: 7:00 PM EST, Dec 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,224,413
Open 33.10
Bid (Size) 31.90 (3)
Ask (Size) 32.10 (1)
Prev. Close 33.92
Today's Range 31.54 - 34.88
52wk Range 8.090 - 35.02
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity. 
Via Investor's Business Daily

Performance

YTD
+227.80%
+227.80%
1 Month
+53.10%
+53.10%
3 Month
+118.99%
+118.99%
6 Month
+46.50%
+46.50%
1 Year
+255.06%
+255.06%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
From Hims & Hers
Via Business Wire
Where Hims & Hers Health Stands With Analysts
Via Benzinga
Exploring growth characteristics of HIMS & HERS HEALTH INC (NYSE:HIMS).
Via Chartmill
Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity
Via Benzinga
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
Via MarketBeat
Topics Government
Exposures COVID-19 Political Product Safety
Why Hims & Hers Stock Jumped on Massive FDA News
Via The Motley Fool
Exposures Product Safety
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Via Benzinga
Price Over Earnings Overview: Hims & Hers Health
Via Benzinga
Should You Buy Hims & Hers Stock on the Dip?
Via The Motley Fool
Technical Monday: A Fresh Look At The “Vanity” Trade
Via Talk Markets
Topics ETFs Stocks / Equities
What's Going On With Hims & Hers Health Stock Monday?
Via Benzinga
Topics Government
Exposures Political
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
Via Benzinga
Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?
Via Benzinga
Hims & Hers New Growth Category Is a Huge Surprise
Via The Motley Fool
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
From Hims & Hers
Via Business Wire
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock?
Via The Motley Fool
Guardant Health Stock Sees RS Rating Jump To 83
Via Investor's Business Daily
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
From Hims & Hers
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 16
Via Talk Markets
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.